CME Group (CME) PT Raised to $281 at Barclays
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
Tweet
Share
E-mailGet Alerts CME Hot Sheet
Price: $295.79 +0.16%
Rating Summary:
13 Buy, 11 Hold, 7 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 17 | New: 31
Rating Summary:
13 Buy, 11 Hold, 7 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 17 | New: 31
Join SI Premium – FREE
Barclays analyst Benjamin Budish raised the price target on CME Group (NASDAQ: CME) to $281.00 (from $270.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- CME Group (CME) Tops Q3 EPS by 4c
- Cleveland-Cliffs (CLF) PT Raised to $18 at B.Riley
- Disc Medicine (IRON) PT Raised to $149 at Jefferies
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
